标题
Ovarian Cancer Targeted Theranostics
作者
关键词
-
出版物
Frontiers in Oncology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2020-01-21
DOI
10.3389/fonc.2019.01537
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status
- (2019) Angiolo Gadducci et al. Journal of Ovarian Research
- Intraperitoneal alpha-emitting radio immunotherapy with Astatine-211 in relapsed ovarian cancer; long-term follow-up with individual absorbed dose estimations
- (2019) Andreas Hallqvist et al. JOURNAL OF NUCLEAR MEDICINE
- Clinical outcomes of 177Lu-PSMA radioligand therapy in taxane chemotherapy pretreated and taxane chemotherapy naïve patients with metastatic castration resistant prostate cancer
- (2019) Thomas W Barber et al. JOURNAL OF NUCLEAR MEDICINE
- Near-Infrared Photoimmunotherapy of Cancer
- (2019) Hisataka Kobayashi et al. ACCOUNTS OF CHEMICAL RESEARCH
- Future of Theranostics: An Outlook on Precision Oncology in Nuclear Medicine
- (2019) Thomas Langbein et al. JOURNAL OF NUCLEAR MEDICINE
- Folate Receptor α-Targeted 89Zr-M9346A Immuno-PET for Image-Guided Intervention with Mirvetuximab Soravtansine in Triple-Negative Breast Cancer
- (2019) Gyu Seong Heo et al. MOLECULAR PHARMACEUTICS
- Safety and Outcome Measures of First-in-Human Intraperitoneal α Radioimmunotherapy With 212Pb-TCMC-Trastuzumab
- (2018) Ruby F. Meredith et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Targeted and Nontargeted α-Particle Therapies
- (2018) Michael R. McDevitt et al. Annual Review of Biomedical Engineering
- Reduced 18F-Folate Conjugates as a New Class of PET Tracers for Folate Receptor Imaging
- (2018) Silvan D. Boss et al. BIOCONJUGATE CHEMISTRY
- Leveraging PET to image folate receptor α therapy of an antibody-drug conjugate
- (2018) Christian Brand et al. EJNMMI Research
- Radiolabeled pertuzumab for imaging of human epidermal growth factor receptor 2 expression in ovarian cancer
- (2017) Dawei Jiang et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha–Targeting Antibody–Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study
- (2017) Kathleen N. Moore et al. JOURNAL OF CLINICAL ONCOLOGY
- Ultrasound Molecular Imaging With BR55 in Patients With Breast and Ovarian Lesions: First-in-Human Results
- (2017) Jürgen K. Willmann et al. JOURNAL OF CLINICAL ONCOLOGY
- First-in-Human Human Epidermal Growth Factor Receptor 2–Targeted Imaging Using89Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
- (2017) Gary A. Ulaner et al. JOURNAL OF NUCLEAR MEDICINE
- Ultrasound molecular imaging of ovarian cancer with CA-125 targeted nanobubble contrast agents
- (2017) Yong Gao et al. Nanomedicine-Nanotechnology Biology and Medicine
- A topically-sprayable, activatable fluorescent and retaining probe, SPiDER-βGal for detecting cancer: Advantages of anchoring to cellular proteins after activation
- (2017) Yuko Nakamura et al. Oncotarget
- Contrast-Enhanced Transvaginal Sonography of Benign Versus Malignant Ovarian Masses
- (2017) Arthur C. Fleischer et al. JOURNAL OF ULTRASOUND IN MEDICINE
- Diagnostic Parameters to Differentiate Benign From Malignant Ovarian Masses With Contrast-Enhanced Transvaginal Sonography
- (2017) Arthur C. Fleischer et al. JOURNAL OF ULTRASOUND IN MEDICINE
- Cancer treatment and survivorship statistics, 2016
- (2016) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia
- (2016) P. Herhaus et al. HAEMATOLOGICA
- Development of Lu-177-trastuzumab for radioimmunotherapy of HER2 expressing breast cancer and its feasibility assessment in breast cancer patients
- (2016) Priya Bhusari et al. INTERNATIONAL JOURNAL OF CANCER
- Preclinical 89Zr Immuno-PET of High-Grade Serous Ovarian Cancer and Lymph Node Metastasis
- (2016) S. K. Sharma et al. JOURNAL OF NUCLEAR MEDICINE
- Ultrasound-mediated destruction of oxygen and paclitaxel loaded lipid microbubbles for combination therapy in hypoxic ovarian cancer cells
- (2016) Jiangchuan Sun et al. ULTRASONICS SONOCHEMISTRY
- Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17
- (2016) Quirijn R.J.G. Tummers et al. Oncotarget
- Near-infrared photoimmunotherapy with galactosyl serum albumin in a model of diffuse peritoneal disseminated ovarian cancer
- (2016) Toshiko Harada et al. Oncotarget
- Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia
- (2016) P. Herhaus et al. HAEMATOLOGICA
- Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha–Targeting Antibody-Drug Conjugate, Potentiates the Activity of Standard of Care Therapeutics in Ovarian Cancer Models
- (2016) Jose F. Ponte et al. NEOPLASIA
- Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial
- (2015) G. Gebhart et al. ANNALS OF ONCOLOGY
- Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study
- (2015) Devansu Tewari et al. JOURNAL OF CLINICAL ONCOLOGY
- Sensitive β-galactosidase-targeting fluorescence probe for visualizing small peritoneal metastatic tumours in vivo
- (2015) Daisuke Asanuma et al. Nature Communications
- Development of a novel liposomal nanodelivery system for bioluminescence imaging and targeted drug delivery in ErbB2-overexpressing metastatic ovarian carcinoma
- (2014) XIAO-JIAN HAN et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Near Infrared Photoimmunotherapy in the Treatment of Disseminated Peritoneal Ovarian Cancer
- (2014) K. Sato et al. MOLECULAR CANCER THERAPEUTICS
- Evaluation of 89Zr-pertuzumab in Breast Cancer Xenografts
- (2014) Bernadette V. Marquez et al. MOLECULAR PHARMACEUTICS
- Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates
- (2014) B. Q. Spring et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antibody-based immunotherapy for ovarian cancer: where are we at?
- (2013) B. W. C. Tse et al. ANNALS OF ONCOLOGY
- Quantitative multiparametric MRI of ovarian cancer
- (2013) Jori S. Carter et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Biologically-Targeted Detection of Primary and Micro-Metastatic Ovarian Cancer
- (2013) Tracy W. Liu et al. Theranostics
- What is the Role of the Bystander Response in Radionuclide Therapies?
- (2013) Darren Brady et al. Frontiers in Oncology
- Recent progress in the diagnosis and treatment of ovarian cancer
- (2011) Danijela Jelovac et al. CA-A CANCER JOURNAL FOR CLINICIANS
- In Vivo Detection of Choline in Ovarian Tumors Using 3D Magnetic Resonance Spectroscopy
- (2011) Anastassia Esseridou et al. INVESTIGATIVE RADIOLOGY
- Imaging of Human Epidermal Growth Factor Receptor Type 2 Expression with 18F-Labeled Affibody Molecule ZHER2:2395 in a Mouse Model for Ovarian Cancer
- (2011) S. Heskamp et al. JOURNAL OF NUCLEAR MEDICINE
- Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results
- (2011) Gooitzen M van Dam et al. NATURE MEDICINE
- Identification of early predictive imaging biomarkers and their relationship to serological angiogenic markers in patients with ovarian cancer with residual disease following cytotoxic therapy
- (2010) C. L. Mitchell et al. ANNALS OF ONCOLOGY
- Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
- (2010) E C Dijkers et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A 2-Helix Small Protein Labeled with 68Ga for PET Imaging of HER2 Expression
- (2009) G. Ren et al. JOURNAL OF NUCLEAR MEDICINE
- Metabolic characterization of primary and metastatic ovarian cancer by1H-MRS in vivo at 3T
- (2009) Mary A. McLean et al. MAGNETIC RESONANCE IN MEDICINE
- Clinical implications of the ErbB/epidermal growth factor (EGF) receptor family and its ligands in ovarian cancer
- (2008) Jacqueline M. Lafky et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- In vivo magnetic resonance spectroscopy of gynaecological tumours at 3.0 Tesla
- (2008) SJ Booth et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Folate receptor alpha as a tumor target in epithelial ovarian cancer
- (2008) Kimberly R. Kalli et al. GYNECOLOGIC ONCOLOGY
- Evaluation of Ovarian Tumors by Proton Magnetic Resonance Spectroscopy at Three Tesla
- (2008) Peter Stanwell et al. INVESTIGATIVE RADIOLOGY
- Epithelial Ovarian Tumors: Value of Dynamic Contrast-enhanced MR Imaging and Correlation with Tumor Angiogenesis
- (2008) Isabelle Thomassin-Naggara et al. RADIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started